Article RDF
pages:- 75
- 76
- 77
- 78
- 79
- 80
- 81
- 82
- 83
- 84
- 85
- 86
- 87
- 88
- 89
- 90
- 91
- 92
- 93
- 94
- 95
- 96
- 97
- 98
- 99
- 100
- 101
- 102
- 103
- 104
- 105
- 106
- 107
- 108
- 109
- 110
- 111
- 112
- 113
- 114
- 115
- more...
- Myonecrosis of the rectus muscle after a Cherney incision.
- Myosin with hypertrophic cardiac mutation R712L has a decreased working stroke which is rescued by omecamtiv mecarbil
- N-Linked Fucosylated Glycans Are Biomarkers for Prostate Cancer with a Neuroendocrine and Metastatic Phenotype
- N-Terminal Domains of Cardiac Myosin Binding Protein C Cooperatively Activate the Thin Filament
- N-Terminal Domains of Cardiac Myosin Binding Protein C Cooperatively Activate the Thin Filament
- NADiA ProsVue Prostate-specific Antigen Slope Is an Independent Prognostic Marker for Identifying Men at Reduced Risk of Clinical Recurrence of Prostate Cancer After Radical Prostatectomy
- NANETS Consensus Guidelines for the Diagnosis of Neuroendocrine Tumor
- Nanomedicine opportunities for cardiovascular disease with perfluorocarbon nanoparticles.
- Nasal allergen challenge (NAC): Practical aspects and applications from an EU/US perspective-a Work Group Report of the AAAAI Rhinitis, Rhinosinusitis and Ocular Allergy Committee
- Nasal Disorders
- Nasal Polyps: Pathogenesis and Treatment Implications
- National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Clinical Practice: Quality Requirements
- National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in clinical practice: quality requirements.
- National efforts to reform residency education in surgery
- National estimates of hospital use by children with HIV infection in the United States: Analysis of data from the 2000 KIDS inpatient database
- National Pediatric Experience With Virtual Interviews: Lessons Learned and Future Recommendations
- National Psoriasis Foundation clinical consensus on disease severity
- National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 1
- National Psoriasis Foundation COVID-19 Task Force guidance for management of psoriatic disease during the pandemic: Version 2-Advances in psoriatic disease management, COVID-19 vaccines, and COVID-19 treatments
- National Psoriasis Foundation COVID-19 Task Force guidance for management of psoriatic disease during the pandemic: Version 2-Advances in psoriatic disease management, COVID-19 vaccines, and COVID-19 treatments
- National Psoriasis Foundation Telemedicine Task Force guidance for management of psoriatic disease via telemedicine
- National Standards in Pathology Education Developing Competencies for Integrated Medical School Curricula
- Natural cycle IVF reduces the risk of low birthweight infants compared with conventional stimulated IVF
- Natural History of Scoliosis in Nonambulatory Spastic Tetraplegic Cerebral Palsy
- NAVIGATE I: Randomized, Placebo-Controlled, Double-Blind Trial of the Exhalation Delivery System With Fluticasone for Chronic Rhinosinusitis With Nasal Polyps Proceedings Paper
- Navigating quality and safety in your health system: understanding the alphabet soup
- Navigating the Complexities in Gender-Diverse Counseling: Understanding the Interplay of Gender Identity, Racial Inequities, Economic Marginalization, and Aging
- Near-Atomic Resolution for One State of F-Actin
- Near-atomic resolution for one state of F-actin.
- Near-simultaneous intensive care unit (ICU) admissions and all-cause mortality: a cohort study.